Literature DB >> 3777984

Intensive chemotherapy for non-localised Burkitt's lymphoma.

A Al-Attar, J Pritchard, T Al-Saleem, M Al-Naimi, N Alash, A Attra.   

Abstract

Between 1982 and 1984, 24 consecutively diagnosed children from Iraq with non-localised Burkitt lymphoma (Murphy stages II, III, and IV) were eligible for treatment with a multi-drug rotating chemotherapy schedule. This schedule was intensive and included early treatment directed at the central nervous system but was of only six months' duration and fairly inexpensive compared with schedules recently advocated for use in the developed world. Some patients had 'debulking' abdominal surgery, but no radiation treatment was used. There were a number of complications related to early treatment, some of them fatal, but of 13 patients entering complete remission 12 are long term survivors who are free of disease and, hopefully, cured. These results represent a substantial improvement over our experience before 1982 (6.9% survival). A similar treatment approach might be adopted by other centres, especially those in developing countries where cancer accounts for a rising proportion of childhood death but whose resources are limited.

Entities:  

Mesh:

Year:  1986        PMID: 3777984      PMCID: PMC1777962          DOI: 10.1136/adc.61.10.1013

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  20 in total

1.  Burkitt's lymphoma in Iraq. Clinical and pathological study of forty-seven patients.

Authors:  A Al-Attar; H Al-Mondhiry; Z Al-Bahrani; T Al-Saleem
Journal:  Int J Cancer       Date:  1979-01-15       Impact factor: 7.396

2.  Treatment results of 54 American patients with Burkitt's lymphoma are similar to the African experience.

Authors:  J L Ziegler
Journal:  N Engl J Med       Date:  1977-07-14       Impact factor: 91.245

Review 3.  Childhood non-Hodgkin's lymphoma.

Authors:  S B Murphy
Journal:  N Engl J Med       Date:  1978-12-28       Impact factor: 91.245

Review 4.  Prognostic features and obstacles to cure of childhood non-Hodgkin's lymphoma.

Authors:  S B Murphy
Journal:  Semin Oncol       Date:  1977-09       Impact factor: 4.929

Review 5.  Renal and metabolic complications of childhood non-Hodgkin's lymphoma.

Authors:  R E Lynch; C M Kjellstrand; P F Coccia
Journal:  Semin Oncol       Date:  1977-09       Impact factor: 4.929

6.  Combined modality treatment of Burkitt's lymphoma.

Authors:  J L Ziegler; I T Magrath; A B Deisseroth; D L Glaubiger; H C Kent; P A Pizzo; D G Poplack; A S Levine
Journal:  Cancer Treat Rep       Date:  1978-12

7.  Prolonged complete remission following high dose chemotherapy of Burkitt's lymphoma in relapse.

Authors:  F R Appelbaum; A B Deisseroth; R G Graw; G P Herzig; A S Levine; I T Magrath; P A Pizzo; D G Poplack; J L Ziegler
Journal:  Cancer       Date:  1978-03       Impact factor: 6.860

8.  Burkitt's lymphoma: a clinical study of 110 patients.

Authors:  F K Nkrumah; I V Perkins
Journal:  Cancer       Date:  1976-02       Impact factor: 6.860

9.  Treatment of Burkitt's lymphoma: randomized clinical trial of single-agent versus combination chemotherapy.

Authors:  C L Olweny; E Katongole-Mbidde; A Kaddu-Mukasa; I Atine; R Owor; S Lwanga; W Carswell; I T Magrath
Journal:  Int J Cancer       Date:  1976-04-15       Impact factor: 7.396

10.  The role of radiation therapy in the treatment of pediatric non-Hodgkin's lymphomas.

Authors:  S C Carabell; J R Cassady; H J Weinstein; N Jaffe
Journal:  Cancer       Date:  1978-11       Impact factor: 6.860

View more
  4 in total

1.  Hepatic late adverse effects after antineoplastic treatment for childhood cancer.

Authors:  Renée L Mulder; Dorine Bresters; Malon Van den Hof; Bart Gp Koot; Sharon M Castellino; Yoon Kong K Loke; Piet N Post; Aleida Postma; László P Szőnyi; Gill A Levitt; Edit Bardi; Roderick Skinner; Elvira C van Dalen
Journal:  Cochrane Database Syst Rev       Date:  2019-04-15

2.  'Debulking' surgery is unnecessary in advanced abdominal Burkitt lymphoma in Iraq.

Authors:  A al-Attar; A Attra; R al-Bagdadi; M al-Naimi; T al-Saleem; J Pritchard
Journal:  Br J Cancer       Date:  1989-04       Impact factor: 7.640

3.  Improved outcome in children with advanced stage B-cell non-Hodgkin's lymphoma (B-NHL): results of the United Kingdom Children Cancer Study Group (UKCCSG) 9002 protocol.

Authors:  A Atra; J D Imeson; R Hobson; M Gerrard; I M Hann; O B Eden; R L Carter; C R Pinkerton
Journal:  Br J Cancer       Date:  2000-04       Impact factor: 7.640

4.  Improved cure rate in children with B-cell acute lymphoblastic leukaemia (B-ALL) and stage IV B-cell non-Hodgkin's lymphoma (B-NHL)--results of the UKCCSG 9003 protocol.

Authors:  A Atra; M Gerrard; R Hobson; J D Imeson; S Ashley; C R Pinkerton
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.